HOME >> MEDICINE >> NEWS
IOM report should end nevirapine controversy, HIVMA says

The HIV Medicine Association (HIVMA) is pleased that the Institute of Medicine (IOM) has reaffirmed nevirapine's safety and efficacy to prevent mother-to-child transmission of HIV.

"IOM has confirmed that nevirapine is a valuable tool to prevent mother-to-child transmission in the many places hardest hit by the AIDS pandemic where no other alternative is available," says obstetrician/gynecologist Susan Cu-Uvin, MD, member of the HIVMA Board of Directors and an AIDS researcher working in the Philippines, Cambodia, and India. "Now we all need to turn our attention to getting the best available anti-AIDS drugs to the millions who need them, including pregnant women."

In its review of HIVNET 012, a study on single-dose nevirapine conducted in Uganda in the late 1990s funded by the National Institutes of Health (NIH), IOM today found that the study was conducted appropriately and ethically, although there were some problems with data collection and record keeping. However, IOM said those errors did not bias the results of the study: that single-dose nevirapine cuts the risk of mother-to-child transmission of HIV nearly in half.

"The IOM panel was made up of some of the most highly respected experts in HIV/AIDS research, biostatistics, and bioethics," says pediatrician Kathryn Edwards, MD, of Vanderbilt University Medical Center, who was a member of the HIVNET Data Safety Monitoring Board. "We're fortunate to have such an esteemed group give their stamp of approval to the study's conduct and findings."

Infectious diseases physician and HIVMA board member Kimberly Smith, MD, MPH adds, "IOM also affirmed the high ethical standards of research conducted under NIH's auspices. We hope this report will help to reassure the developing world about the good intentions of AIDS researchers."


'"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
8-Apr-2005


Page: 1

Related medicine news :

1. Controlling prescription drug expenditures: a case report of success
2. U of M report says early-childhood intervention improves well-being through young adulthood
3. Scientists train nano-building blocks to take on new shapes, as reported in Science
4. First of its kind report on how children with brain tumors perform at school
5. Needle-stick injuries are common but unreported by surgeons in training
6. New study reports hotel guests at risk from carbon monoxide poisoning
7. Study examines characteristics of female high school students who report steroid use
8. Researcher says few families report safe firearm storage
9. New Orleans levee report finished by panel including University of Texas at Austin engineer
10. New system for reporting toxicity burden of cancer treatment
11. Texas aging meeting to feature NIA Interventions Testing Program 1st report

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: IOM report should end nevirapine controversy HIVMA says

(Date:10/31/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... the U.S. indoor air quality (IAQ) market is expected to ... growth rate (CAGR) of 7% over the next five years. ... CAGR of 7.4%. , Since 2012, continuing media attention ... of infectious diseases such as bird flu and the increase ...
(Date:10/31/2014)... Boca Raton, FL (PRWEB) October 31, 2014 ... wellness company founded on the highest principles of patient ... Lifescript , a leading health and wellness website, to ... those living with diabetes. , The Diabetes Health ... tips and recipes for those living with diabetes. Content ...
(Date:10/31/2014)... News) -- Carving pumpkins and trick-or-treating may seem like ... emergency rooms in the United States every year, experts ... fifth highest number of ER visits involving children aged ... the National Electronic Injury Surveillance System. Nearly ... the American Academy of Orthopaedic Surgeons and the Pediatric ...
(Date:10/31/2014)... to generic hormone therapy medicines improves the chances that ... a new study found. "We know that hormone ... reduce recurrence by up to 50 percent," study leader ... Columbia University Medical Center in New York City, said ... by our group and others has shown that a ...
(Date:10/31/2014)... News) -- There are clear differences in the brains ... of healthy people, new research indicates. Scientists ... could help doctors diagnose this baffling condition and shed ... syndrome are often misdiagnosed or labeled as hypochondriacs. ... "we found that [chronic fatigue syndrome] patients, brains diverge ...
Breaking Medicine News(10 mins):Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:Halloween at the ER Is No Treat 2Health News:Generic Drugs May Help Breast Cancer Patients Stick to Therapy 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 3
(Date:10/31/2014)... Investor-Edge has initiated coverage on the following equities: ... ABT ), Hologic Inc. (NASDAQ: HOLX ... PLC (NYSE: COV). Free research on these five companies can ... markets on Thursday, October 30, 2014, ended on a positive ... up 1.30% and the NASDAQ Composite closed at 4,566.14, up ...
(Date:10/31/2014)...  Zebra Imaging, Inc., the world,s foremost provider ... strategic partnership with the Zygote Media Group Inc., ... biomedical models for animation and visual effects, to ... maintains the world,s most comprehensive library of accurate ... development of high-end solid 3D anatomy models for ...
(Date:10/31/2014)... , Oct. 31, 2014  Australian biopharmaceutical company Specialised ... (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will ... patients with metastatic pancreatic cancer from 1 November. ... cancer is the 5 th most common cause ... all cancer deaths, with the lowest 5-year survival of ...
Breaking Medicine Technology:Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 2Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 3Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 4Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 5Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8
Cached News: